BeyondSpring Competitors and Similar CompaniesClear all
BeyondSpring's competitors and similar companies include Omeros, Otonomy and Leap Therapeutics.
 BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. |  Otonomy Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear. |  Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. | |
Founding Date | Founding Date 2010 | Founding Date 1994 | Founding Date 2008 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Florham Park, US HQ | Locations Seattle, US HQ | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 4014% increase | Employees 1968% decrease | Employees 49 | Employees 688% decrease |
Valuation ($) | Valuation ($) 89.4 m | Valuation ($) 248.6 m | Valuation ($) 5.3 m | Valuation ($) 176.4 m |
Financial | ||||
Net income | Net income ($16.7m) (FY, 2024) | Net income ($3.4m) (FY, 2025) | Net income ($51.2m) (FY, 2021) | Net income $4.8m (FY, 2025) |
Operating ⚠ | ||||
Patents (US) | Patents (US) 20 (Mar, 2020) | Patents (US) 80 (FY, 2021) | Patents (US) N/A | Patents (US) N/A |
Phase I Trials Products | Phase I Trials Products 2 (FY, 2019) | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 1 (FY, 2017) | Phase II Trials Products 2 (FY, 2021) | Phase II Trials Products 2 (FY, 2016) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 3 (FY, 2019) | Phase III Trials Products 2 (FY, 2021) | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products N/A |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 5 (FY, 2019) | Pre-Clinical Phase Products N/A | Pre-Clinical Phase Products 1 (FY, 2016) | Pre-Clinical Phase Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 36.1m | Total funding raised $ 354.8m | Total funding raised $ 153.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Omeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View companyOtonomy
HQ
San Diego, US
Employees
49
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
View companyLeap Therapeutics
HQ
Cambridge, US
Employees
6
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View company